PTEN and melanoma: PTEN regulates the phosphotidylinositol-3-kinase (PI3K) pathway, which is a well-studied oncogenic pathway in multiple cancer types These observations have invigorated PI3K and BRAF dual inhibition strategies in patients with PTEN null melanoma [86].